You are here

Article Text

Article menu
Download PDFPDF
Case Report
Fatal pulmonary Mycobacterium xenopi in a patient with rheumatoid arthritis receiving etanercept
  1. Nimrod Maimon1,
  2. James Brunton2,
  3. Adrienne K Chan2,
  4. Theodore K Marras3
  1. 1Division of Respirology, University Health Network and Mount Sinai Hospital, Department of Medicine, University of Toronto, Toronto, Canada
  2. 2Division of Infectious Diseases, University Health Network and Mount Sinai Hospital, Department of Medicine, University of Toronto, Toronto, Canada
  3. 3Department of Respiratory Medicine, University Health Network and Mount Sinai Hospital, Department of Medicine, University of Toronto, Toronto, Canada
  1. Correspondence to:
    Dr Theodore K Marras
    Toronto Western Hospital, 7 East, Room 452, 399 Bathurst Street, Toronto, Ontario, Canada M5T 2S8; ted.marras{at}utoronto.ca

Abstract

Mycobacterium xenopi is a water-related mycobacterium with low pathogenicity in humans. Little is known about the association between anti-tumour necrosis factor (TNF)α and non-tuberculous mycobacterial infections. The case history is presented of fatal M xenopi infection in a patient receiving anti-TNFα treatment.

  • TNFα, tumour necrosis factor α

https://doi.org/10.1136/thx.2005.056952

Statistics from Altmetric.com

    Request Permissions

    If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.

    View Full Text

    Footnotes

    • NM is supported by the Princess Margaret Hospital Foundation, Toronto, Canada and SACTA-RASHI Foundation, Israel.

    • Competing interests: None.